#,ama,title,journal,year,volume,issue,pages,doi,pmid,authors
1,"Light RW, Girard WM, Jenkinson SG, George RB. Parapneumonic effusions. Am J Med. 1980;69.",Parapneumonic effusions,Am J Med,1980,69,,,,,Light RW; Girard WM; Jenkinson SG; George RB
2,"Desrumaux A, François P, Pascal C. Epidemiology and clinical characteristics of childhood parapneumonic empyemas. Arch Pediatr. 2007;14.",Epidemiology and clinical characteristics of childhood parapneumonic empyemas,Arch Pediatr,2007,14,,,,,Desrumaux A; François P; Pascal C
3,"Roxburgh CS, Youngson GG. Childhood empyema in North-East Scotland over the past 15 years. Scott Med J. 2007;52.",Childhood empyema in North-East Scotland over the past 15 years,Scott Med J,2007,52,,,,,Roxburgh CS; Youngson GG
4,"Muñoz-Almagro C, JI, Latorre GA, Garcia-Garcia C, Pallares JJ, R. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis. 2008;46.",Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine,Clin Infect Dis,2008,46,,,,,Muñoz-Almagro C; JI; Latorre GA; Garcia-Garcia C; Pallares JJ; R
5,"Farjah F, Symons RG, Krishnadasan B, Wood DE, Flum DR. Management of pleural space infections: a population-based analysis. J Thorac Cardiovasc Surg. 2007;133.",Management of pleural space infections: a population-based analysis,J Thorac Cardiovasc Surg,2007,133,,,,,Farjah F; Symons RG; Krishnadasan B; Wood DE; Flum DR
6,"Finley C, Clifton J, Fitzgerald JM, Yee J. Empyema: an increasing concern in Canada. Can Respir J. 2008;15.",Empyema: an increasing concern in Canada,Can Respir J,2008,15,,,,,Finley C; Clifton J; Fitzgerald JM; Yee J
7,"Ferguson AD, Prescott RJ, Selkon JB, Watson D, Swinburn CR. The clinical course and management of thoracic empyema. QJM. 1996;89.",The clinical course and management of thoracic empyema,QJM,1996,89,,,,,Ferguson AD; Prescott RJ; Selkon JB; Watson D; Swinburn CR
8,"Davies CW, Kearney SE, Gleeson FV, Davies RJ. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med. 1999;160.",Predictors of outcome and long-term survival in patients with pleural infection,Am J Respir Crit Care Med,1999,160,,,,,Davies CW; Kearney SE; Gleeson FV; Davies RJ
9,"Maskell NA, Davies C, Nunn AJ. controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005;352:2146.",controlled trial of intrapleural streptokinase for pleural infection,N Engl J Med,2005,352,,2146,,,Maskell NA; Davies C; Nunn AJ
10,"Sonnappa S, Cohen G, Owens CM. Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema. Am J Respir Crit Care Med. 2006;174.",Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema,Am J Respir Crit Care Med,2006,174,,,,,Sonnappa S; Cohen G; Owens CM
11,"Netten A, Dennett J, Knight J. Unit costs of health and social care. Unit costs of health and social care. 1999;None.",Unit costs of health and social care,Unit costs of health and social care,1999,,,,,,Netten A; Dennett J; Knight J
12,"Davies RJ, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax. 1997;52.",Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection,Thorax,1997,52,,,,,Davies RJ; Traill ZC; Gleeson FV
13,"Bouros D, Schiza S, Tzanakis N, Chalkiadakis G, Drositis J, Siafakas N. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema: a randomized, double-blind study. Am J Respir Crit Care Med. 1999;159.","Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema: a randomized, double-blind study",Am J Respir Crit Care Med,1999,159,,,,,Bouros D; Schiza S; Tzanakis N; Chalkiadakis G; Drositis J; Siafakas N
14,"Tuncozgur B, Ustunsoy H, Sivrikoz MC. Intrapleural urokinase in the management of parapneumonic empy-The New England Journal of Medicine Downloaded from nejm. Int J Clin Pract. 2001;55.",Intrapleural urokinase in the management of parapneumonic empy-The New England Journal of Medicine Downloaded from nejm,Int J Clin Pract,2001,55,,,,,Tuncozgur B; Ustunsoy H; Sivrikoz MC
15,"Talib SH, Verma GR, Arshad M, Tayade BO, Rafeeque A. Utility of intrapleural streptokinase in management of chronic empyemas. J Assoc Physicians India. 2003;51.",Utility of intrapleural streptokinase in management of chronic empyemas,J Assoc Physicians India,2003,51,,,,,Talib SH; Verma GR; Arshad M; Tayade BO; Rafeeque A
16,"Diacon AH, Schuurmans TJ, Van De Wal MM, Bolliger BW, CT. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med. 2004;170.",Intrapleural streptokinase for empyema and complicated parapneumonic effusions,Am J Respir Crit Care Med,2004,170,,,,,Diacon AH; Schuurmans TJ; Van De Wal MM; Bolliger BW; CT
17,"Misthos P, Sepsas E, Konstantinou M, Athanassiadi K, Skottis I, Lioulias A. Early use of intrapleural fibrinolytics in the management of postpneumonic empyema: a prospective study. Eur J Cardiothorac Surg. 2005;28.",Early use of intrapleural fibrinolytics in the management of postpneumonic empyema: a prospective study,Eur J Cardiothorac Surg,2005,28,,,,,Misthos P; Sepsas E; Konstantinou M; Athanassiadi K; Skottis I; Lioulias A
18,"Tokuda Y, Matsushima D, Stein GH, Miyagi S. Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis. Chest. 2006;129.",Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis,Chest,2006,129,,,,,Tokuda Y; Matsushima D; Stein GH; Miyagi S
19,Heffner JE. Multicenter trials of treatment for empyema -after all these years. N Engl J Med. 2005;352.,Multicenter trials of treatment for empyema -after all these years,N Engl J Med,2005,352,,,,,Heffner JE
20,"Walker CA, Shirk MB, Tschampel MM, Visconti JA. Intrapleural alteplase in a patient with complicated pleural effusion. Ann Pharmacother. 2003;37.",Intrapleural alteplase in a patient with complicated pleural effusion,Ann Pharmacother,2003,37,,,,,Walker CA; Shirk MB; Tschampel MM; Visconti JA
21,"Skeete DA, Rutherford EJ, Schlidt SA, Abrams JE, Parker LA, Rich PB. Intrapleural tissue plasminogen activator for complicated pleural effusions. J Trauma. 2004;57.",Intrapleural tissue plasminogen activator for complicated pleural effusions,J Trauma,2004,57,,,,,Skeete DA; Rutherford EJ; Schlidt SA; Abrams JE; Parker LA; Rich PB
22,"Feola GP, Shaw LC, Coburn L. Management of complicated parapneumonic effusions in children. Tech Vasc Interv Radiol. 2003;6.",Management of complicated parapneumonic effusions in children,Tech Vasc Interv Radiol,2003,6,,,,,Feola GP; Shaw LC; Coburn L
23,"Bishop NB, Pon S, Ushay HM, Greenwald BM. Alteplase in the treatment of complicated parapneumonic effusion: a case report. Pediatrics. 2003;111(2).",Alteplase in the treatment of complicated parapneumonic effusion: a case report,Pediatrics,2003,111,2,,,,Bishop NB; Pon S; Ushay HM; Greenwald BM
24,"Wells RG, Havens PL. Intrapleural fibrinolysis for parapneumonic effusion and empyema in children. Radiology. 2003;228.",Intrapleural fibrinolysis for parapneumonic effusion and empyema in children,Radiology,2003,228,,,,,Wells RG; Havens PL
25,"Weinstein M, Restrepo R, Chait PG, Connolly B, Temple M, Macarthur C. Effectiveness and safety of tissue plasminogen activator in the management of complicated parapneumonic effusions. Pediatrics. 2004;113(3).",Effectiveness and safety of tissue plasminogen activator in the management of complicated parapneumonic effusions,Pediatrics,2004,113,3,,,,Weinstein M; Restrepo R; Chait PG; Connolly B; Temple M; Macarthur C
26,"Ray TL, Berkenbosch JW, Russo P, Tobias JD. Tissue plasminogen activator as an adjuvant therapy for pleural empyema in pediatric patients. J Intensive Care Med. 2004;19.",Tissue plasminogen activator as an adjuvant therapy for pleural empyema in pediatric patients,J Intensive Care Med,2004,19,,,,,Ray TL; Berkenbosch JW; Russo P; Tobias JD
27,"Gates RL, Hogan M, Weinstein S, Arca MJ. Drainage, fibrinolytics, or surgery: a comparison of treatment options in pediatric empyema. J Pediatr Surg. 2004;39.","Drainage, fibrinolytics, or surgery: a comparison of treatment options in pediatric empyema",J Pediatr Surg,2004,39,,,,,Gates RL; Hogan M; Weinstein S; Arca MJ
28,"Hall-Stoodley L, Nistico L, Sambantha Moorthy K. Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in Streptococcus pneumoniae clinical isolates. BMC Microbiol. 2008;8:173.","Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in Streptococcus pneumoniae clinical isolates",BMC Microbiol,2008,8,,173,,,Hall-Stoodley L; Nistico L; Sambantha Moorthy K
29,"Thomas VC, Thurlow LR, Boyle D, Hancock LE. Regulation of autolysisdependent extracellular DNA release by Enterococcus faecalis extracellular proteases influences biofilm development. J Bacteriol. 2008;190.",Regulation of autolysisdependent extracellular DNA release by Enterococcus faecalis extracellular proteases influences biofilm development,J Bacteriol,2008,190,,,,,Thomas VC; Thurlow LR; Boyle D; Hancock LE
30,"Izano EA, Amarante MA, Kher WB, Kaplan JB. Differential roles of poly-Nacetylglucosamine surface polysaccharide and extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis biofilms. Appl Environ Microbiol. 2008;74.",Differential roles of poly-Nacetylglucosamine surface polysaccharide and extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis biofilms,Appl Environ Microbiol,2008,74,,,,,Izano EA; Amarante MA; Kher WB; Kaplan JB
31,"Eckhart L, Fischer H, Barken KB, Tolker-Nielsen T, Tschachler E. DNase1L2 suppresses biofilm formation by Pseudomonas aeruginosa and Staphylococcus aureus. Br J Dermatol. 2007;156.",DNase1L2 suppresses biofilm formation by Pseudomonas aeruginosa and Staphylococcus aureus,Br J Dermatol,2007,156,,,,,Eckhart L; Fischer H; Barken KB; Tolker-Nielsen T; Tschachler E
32,"Nemoto K, Hirota K, Murakami K. Effect of Varidase (streptodornase) on biofilm formed by Pseudomonas aeruginosa. Chemotherapy. 2003;49.",Effect of Varidase (streptodornase) on biofilm formed by Pseudomonas aeruginosa,Chemotherapy,2003,49,,,,,Nemoto K; Hirota K; Murakami K
33,"Light RW, Nguyen T, Mulligan ME, Sasse SA. The in vitro efficacy of Varidase versus streptokinase or urokinase for liquefying thick purulent exudative material from loculated empyema. Lung. 2000;178.",The in vitro efficacy of Varidase versus streptokinase or urokinase for liquefying thick purulent exudative material from loculated empyema,Lung,2000,178,,,,,Light RW; Nguyen T; Mulligan ME; Sasse SA
34,"Simpson G, Roomes D, Heron M. Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus. Chest. 2000;117.",Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus,Chest,2000,117,,,,,Simpson G; Roomes D; Heron M
35,"Zhu Z, Hawthorne ML, Guo Y. Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model. Chest. 2006;129.",Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model,Chest,2006,129,,,,,Zhu Z; Hawthorne ML; Guo Y
36,"Simpson G, Roomes D, Reeves B. Successful treatment of empyema thoracis with human recombinant deoxyribonuclease. Thorax. 2003;58.",Successful treatment of empyema thoracis with human recombinant deoxyribonuclease,Thorax,2003,58,,,,,Simpson G; Roomes D; Reeves B
37,"Fujiwara K, Yasumitsu T, Nakagawa K, Shiono S, Fukuhara K. Intrapleural streptokinase-streptodornase in the treatment of empyema and hemothorax. Kyobu Geka. 2002;55.",Intrapleural streptokinase-streptodornase in the treatment of empyema and hemothorax,Kyobu Geka,2002,55,,,,,Fujiwara K; Yasumitsu T; Nakagawa K; Shiono S; Fukuhara K
38,"Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics. 1975;31.",Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial,Biometrics,1975,31,,,,,Pocock SJ; Simon R
39,"Montgomery AA, Peters TJ, Little P. Design, analysis and presentation of factorial randomised controlled trials. BMC Med Res Methodol. 2003;3:26.","Design, analysis and presentation of factorial randomised controlled trials",BMC Med Res Methodol,2003,3,,26,,,Montgomery AA; Peters TJ; Little P
40,"Pocock SJ, Assmann SE, Enos LE, Kasten LE. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Stat Med. 2002;21.","Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems",Stat Med,2002,21,,,,,Pocock SJ; Assmann SE; Enos LE; Kasten LE
41,"Hagino A, Hamada C, Yoshimura I, Ohashi Y, Sakamoto J, Nakazato H. Statistical comparison of random allocation methods in cancer clinical trials. Control Clin Trials. 2004;25.",Statistical comparison of random allocation methods in cancer clinical trials,Control Clin Trials,2004,25,,,,,Hagino A; Hamada C; Yoshimura I; Ohashi Y; Sakamoto J; Nakazato H
42,"Rovers MM, Straatman H, Zielhuis GA. Comparison of balanced and random allocation in clinical trials: a simulation study. Eur J Epidemiol. 2000;16.",Comparison of balanced and random allocation in clinical trials: a simulation study,Eur J Epidemiol,2000,16,,,,,Rovers MM; Straatman H; Zielhuis GA
43,Forsthye A. Validity and power of tests when groups have been balanced for prognostic factors. Comput Stat Data Anal. 1987;5.,Validity and power of tests when groups have been balanced for prognostic factors,Comput Stat Data Anal,1987,5,,,,,Forsthye A
44, A trial of intrapleural streptokinase. N Engl J Med. 2005;352.,A trial of intrapleural streptokinase,N Engl J Med,2005,352,,,,,
45,"Diacon AH, Koegelenberg C, Bolliger CT. A trial of intrapleural streptokinase. N Engl J Med. 2005;352:2243.",A trial of intrapleural streptokinase,N Engl J Med,2005,352,,2243,,,Diacon AH; Koegelenberg C; Bolliger CT
46,Bouros D. A trial of intrapleural streptokinase. N Engl J Med. 2005;352:2244.,A trial of intrapleural streptokinase,N Engl J Med,2005,352,,2244,,,Bouros D
47,Keenan SP. Streptokinase did not reduce mortality or need for surgical drainage in pleural infection. ACP J Club. 2005;143:40.,Streptokinase did not reduce mortality or need for surgical drainage in pleural infection,ACP J Club,2005,143,,40,,,Keenan SP
48,Rosa UW. A trial of intrapleural streptokinase. N Engl J Med. 2005;352:2244.,A trial of intrapleural streptokinase,N Engl J Med,2005,352,,2244,,,Rosa UW
49,"Idell S, Zwieb C, Kumar A, Koenig KB, Johnson AR. Pathways of fibrin turnover of human pleural mesothelial cells in vitro. Am J Respir Cell Mol Biol. 1992;7.",Pathways of fibrin turnover of human pleural mesothelial cells in vitro,Am J Respir Cell Mol Biol,1992,7,,,,,Idell S; Zwieb C; Kumar A; Koenig KB; Johnson AR
50,"Kroegel C, Vb A. Immunobiology of pleural inflammation: potential implications for pathogenesis, diagnosis and therapy. Eur Respir J. 1997;10.","Immunobiology of pleural inflammation: potential implications for pathogenesis, diagnosis and therapy",Eur Respir J,1997,10,,,,,Kroegel C; Vb A
51,"Florova G, Komissarov A, Idell S. DNA dramatically potentiates activation of plasminogen by tissue type plasminogen activator. Am J Respir Crit Care Med. 2010;181:6824.",DNA dramatically potentiates activation of plasminogen by tissue type plasminogen activator,Am J Respir Crit Care Med,2010,181,,6824,,,Florova G; Komissarov A; Idell S
52,"Alipour M, Suntres ZE, Omri A. Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa. J Antimicrob Chemother. 2009;64.",Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa,J Antimicrob Chemother,2009,64,,,,,Alipour M; Suntres ZE; Omri A
53,"Poulsen J, Kristensen VN, Brygger HE, Delikaris P. Treatment of infected surgical wounds with Varidase. Acta Chir Scand. 1983;149.",Treatment of infected surgical wounds with Varidase,Acta Chir Scand,1983,149,,,,,Poulsen J; Kristensen VN; Brygger HE; Delikaris P
54,Suomalainen O. Evaluation of two enzyme preparations -Trypure and Varidase in traumatic ulcers. Ann Chir Gynaecol. 1983;72.,Evaluation of two enzyme preparations -Trypure and Varidase in traumatic ulcers,Ann Chir Gynaecol,1983,72,,,,,Suomalainen O
